U.S. markets open in 13 minutes

Ra Medical Systems, Inc. (RMED)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
5.75-1.31 (-18.56%)
At close: 4:00PM EST

6.08 +0.33 (5.74%)
Pre-Market: 9:00AM EST

Sign in to post a message.
  • J
    Jeff
    When is this thing going to hold $7?
  • K
    KiwiBrit
    Ra Medical announces extension of DABRA catheter shelf life
    Jan. 27, 2021 3:52 PM ETRa Medical Systems, Inc. (RMED)By: Vandana Singh, SA News Editor
    Ra Medical Systems (RMED -11.9%) reports progress with extending the shelf life of its DABRA catheter of six months or longer, featuring a braided overjacket to improve deliverability. It also said that it has completed all 116 items identified in a quality improvement plan that stemmed from an internal audit in late 2019.
    Though the Company is still implementing multiple remediations to address two primary issues related to the catheter’s limited shelf life as being the introduction of unwanted elements into its core water and the degradation of its inner coating. Engineering work for this catheter is expected to complete by mid-2021 and subsequently submit to the FDA for clearance.
    Dabra excimer laser system is currently in pivotal clinical trial to evaluate the safety and effectiveness as an atherectomy device for the treatment of peripheral arterial disease. Primary efficacy endpoint is the mean reduction in percent diameter stenosis in primary lesion following treatment with Dabra, before any adjunctive treatment.
    Dabra received FDA nod in May 2017 for use in ablating a channel in occlusive peripheral vascular disease.
    The company settled investigations into whether the company made false marketing claims when seeking FDA clearance for Dabra catheter for cardiovascular and skin conditions, earlier in month.
  • K
    KiwiBrit
    Ra Medical resolves DOJ false claims investigations
    Jan. 04, 2021 4:03 PM ETRa Medical Systems, Inc. (RMED)By: Vandana Singh, SA News Editor1 Comment
    Ra Medical Systems closed (RMED -4.8%) after settling federal and state investigations into whether the company made false marketing claims when seeking FDA clearance for its laser ablation treatment for cardiovascular and skin conditions.
    The investigation by the U.S. Department of Justice was first disclosed in October 2019, when an audit committee found that the company’s Dabra catheter—a disposable, minimally invasive excimer system designed to break down artery-blocking plaque deposits—”frequently failed to calibrate and occasionally overheated,” risking injury to patients and physicians. The audit also found Ra Medical failed to immediately report the issues to the FDA and began quiet product recalls.
    The settlement with the DOJ, in which Ra Medical does not admit any liability or wrongdoing, as well as includes tentative agreements with participating states that could resolve separate investigations by state attorneys general, the company said.
    Ra Medical will pay an initial $2.5M, plus more depending on future revenues. If sales exceed $10M annually in any of the next four years, the company will be required to pay $500k for 2021, $750k for 2022, $1M for 2023 and $1.25M for 2024.
    Additionally, if the company is bought before the end of 2024, it will be required to pay another $5M, plus 4% of the deal’s value if the transaction tops $100M.
  • C
    Chris
    Long term pt 30... But have to wait...
  • F
    Fabrizio
    Big potential there, it was at 500$ remember
  • C
    Chris
    This is a real f up company... Other shares has been up and green many days... This piece of sheet is always 6.66, 6.76, 6.96,... Just sell and go peeps...don't come back at all...
  • V
    V.
    RMED continues its climb. The chart is looking great - poised for a breakout any day now.
    Bullish
  • C
    Chris
    Could it be wallstreetbet army?
  • V
    V.
    RMED beginning its climb back up.
  • T
    TrickleDown
    DD : $RMED DD :

    Current mkt cap: $25mm
    Cash on hand: $34mm
    Float: 2.4mm
    20% insider owned
    15% tute owned

    Trading in the $8.00s as of today.
    Cash value about $13.90 (using yahoo). Just about the same level as the 200ma.
    Designs, develops, & commercializes excimer lasers as tools for the treatment of vascular and dermatological diseases.
    Two FDA approved technologies:
    📍 DABRA
    📍 PHAROS
    Total addressable market (TAM) believed to be $550M+.
    TAM = revenue opportunity.
    Holds 8 patents (US & international) covering several aspects of their laser systems.
    Appointed new CEO earlier this year, Will McGuire.
    📍 Formerly the CEO of $EYES
    📍 Formerly the COO of Spectranetics, which was acquired by Philips $PHG for $2.2B / $38.50 per share (27% premium to last trading price).
    Raised $12mm in August via offering @ .35/share. Adjusted for November 1/25 RS = $8.75 offering price
  • T
    TrickleDown
    Powerful move on volume.
    My sell is set high and forgetting it. Trap the shorts. CASH ON HAND VALUE IS $14 and book is $28. Insiders have been loading. Trial update expected.
    First PT is $14 then $28. ONLY 2.8M Float. Volume here is volatile and primed for a huge move!
  • V
    V.
    RMED moving nicely to reach new highs. I'm so glad I bought my shares at lower prices, but I've added some more.
  • j
    jojo
    back to $25 any day
    Bullish
  • F
    Fabrizio
    Good news
    Bullish
  • J
    Jeff
    What are the next catalysts for the company?
  • Y
    Yahoo Finance Insights
    Ra Medical Systems is up 13.50% to 8.84
  • T
    TrickleDown
    $RMED - big volume early for them. 2.9M float, $34M cash and $20m market cap! NO DEBT, INSIDERS JUST LOADED. Cash value is $14. Book value is $28.

    I bought 2.7% of the company pre split. $20+ is coming.....
  • A
    Anonymous
    Hedge funds bought last quarter and the insides bought recently is a strong catalyst that the price is gonna move up after base consolidation. Tipranks target $16
    Bullish
  • T
    TrickleDown
    $RMED - Beautiful Gap close and consolidation today.

    STILL only $24M market cap with $34M cash
    Cash value is $13.50 Book value is $28
    Traded 2.1M shares today on a 2.9M float!!
    #market #Stocks #fintwit #StockMarket !!
  • W
    Wallace
    15% up!!!
    Bullish